CompaniesASIT Biotech

ASIT Biotech

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

660

By Phase

PHASE3: 1PHASE2: 1

By Status

UNKNOWN: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2015

2016

2017

2018

2019

2020

Today

Hover over trial bars to see details

Recent Trials

NCT03724240Lead Sponsor

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

624 participants

Started: Jan 2, 2019 · Completed: Dec 31, 2019

NCT03094845Lead Sponsor

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

PHASE2Completed

36 participants

Started: Sep 28, 2016 · Completed: Jan 23, 2017